Pennant Investors, LP
Follow13F filer, CIK 1759176, Summit, NJ
Pennant Investors, LP reported $350,297,156 across 16 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 89.76% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-24-006577
- Period
- 2024-09-30
- Reported value
- $350M
- Holdings
- 16
- Top 10 weight
- 89.76%
- New
- 1
- Sold out
- 31
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ARadded | +290,000 | $8.31M |
| ASMLnew | +6,500 | $5.42M |
| PERIMETER SOLUTIONS SAadded | +400,000 | $5.38M |
| VRTadded | +45,000 | $4.48M |
| ECHOadded | +167,628 | $4.16M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TDGreduced | -13,000 | -$18.6M |
| ODPexited | -400,000 | -$15.7M |
| MSFTreduced | -29,000 | -$12.5M |
| AMZNreduced | -58,000 | -$10.8M |
| MUreduced | -90,568 | -$9.39M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000919574-24-006577, largest first. % of portfolio is the value over $335,972,156, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ECHOECHOSTAR CORP | 2,320,837 | $57.6M | 17.15% | +167,628 | Timeline | ||
| PERIMETER SOLUTIONS SAPERIMETER SOLUTIONS SA | 2,700,000 | $36.3M | 10.81% | +400,000 | |||
| MUMICRON TECHNOLOGY INC | 340,432 | $35.3M | 10.51% | -90,568 | Timeline | ||
| AMZNAMAZON COM INC | 182,000 | $33.9M | 10.09% | -58,000 | Timeline | ||
| ARANTERO RESOURCES CORP | 1,126,000 | $32.3M | 9.6% | +290,000 | Timeline | ||
| TDGTRANSDIGM GROUP INC | 19,371 | $27.6M | 8.23% | -13,000 | Timeline | ||
| GOOGLALPHABET INC | 153,000 | $25.4M | 7.55% | -30,000 | Timeline | ||
| MSFTMICROSOFT CORP | 51,000 | $21.9M | 6.53% | -29,000 | Timeline | ||
| VRTVERTIV HOLDINGS CO | 160,000 | $15.9M | 4.74% | +45,000 | Timeline | ||
| GEVGE VERNOVA INC | 60,000 | $15.3M | 4.55% | 0 | Timeline | ||
| VMIVALMONT INDS INC | 40,000 | $11.6M | 3.45% | 0 | Timeline | ||
| CORZCORE SCIENTIFIC INC NEW | 794,813 | $9.43M | 2.81% | +294,813 | Timeline | ||
| IRENIREN LIMITED | 940,000 | $7.93M | 2.36% | +470,000 | Timeline | ||
| ASMLASML HLDG NV | 6,500 | $5.42M | 1.61% | new | Timeline | ||
| GRABWGRAB HOLDINGS LIMITED | 80,000 | $19.1K | 0.01% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| ARANTERO RESOURCES CORP Stock | call | 500,000 | $14.3M | 0 |
Sold out in Q3 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ODPTHE ODP CORP | 400,000 | $15.7M | shares |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 170,900 | $1.59M | shares |
| NRIXNURIX THERAPEUTICS INC | 56,800 | $1.19M | shares |
| NVAXNOVAVAX INC | 60,300 | $763K | shares |
| ALTALTIMMUNE INC | 109,800 | $730K | shares |
| FIBROGEN INCFIBROGEN INC | 768,400 | $686K | shares |
| AGIOAGIOS PHARMACEUTICALS INC | 15,100 | $651K | shares |
| FATEFATE THERAPEUTICS INC | 146,100 | $479K | shares |
| TVTXTRAVERE THERAPEUTICS INC | 55,800 | $459K | shares |
| ENTAENANTA PHARMACEUTICALS INC | 35,100 | $455K | shares |
| IGM BIOSCIENCES INCIGM BIOSCIENCES INC | 64,900 | $446K | shares |
| ERASERASCA INC | 166,200 | $392K | shares |
| RCUSARCUS BIOSCIENCES INC | 23,700 | $361K | shares |
| 89BIO INC89BIO INC | 44,500 | $356K | shares |
| ZYMEZYMEWORKS INC | 38,700 | $329K | shares |
| ARCTARCTURUS THERAPEUTICS HLDGS | 13,100 | $319K | shares |
| ALLOALLOGENE THERAPEUTICS INC | 128,400 | $299K | shares |
| CHRSCOHERUS ONCOLOGY INC | 168,100 | $291K | shares |
| RLAYRELAY THERAPEUTICS INC | 42,400 | $276K | shares |
| REPLREPLIMUNE GROUP INC | 30,500 | $274K | shares |
| QUREUNIQURE NV | 48,500 | $217K | shares |
| SERES THERAPEUTICS INCSERES THERAPEUTICS INC | 292,300 | $212K | shares |
| CMPXCOMPASS THERAPEUTICS INC | 199,000 | $199K | shares |
| SAGE THERAPEUTICS INCSAGE THERAPEUTICS INC | 17,500 | $190K | shares |
| GETRGETAROUND INC COM | 1,348,153 | $189K | shares |
| MGNXMACROGENICS INC | 43,800 | $186K | shares |
| ALLAKOS INCALLAKOS INC | 186,100 | $186K | shares |
| ALLOVIR INCALLOVIR INC | 215,700 | $156K | shares |
| ZNTLZENTALIS PHARMACEUTICALS INC | 32,400 | $133K | shares |
| BIOXCEL THERAPEUTICS INCBIOXCEL THERAPEUTICS INC | 83,900 | $107K | shares |
| BLUEBIRD BIO INCBLUEBIRD BIO INC | 87,400 | $86K | shares |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-24-006577 | base | 2024-11-14 | acceptance time not in the bulk data set |